The Effect Of Therapeutic Touch On Lone… | Clinical Trial

Key information

Conditions

Loneliness Hope

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ZEHRA, Bayram, Turkey (Türkiye)

About this study

Chronic diseases are a challenging process that affects human life physiologically and psychologically. Chronic Renal Failure, which shows a significant increase in the world and in our country, also affects human life in every aspect. Hemodialysis treatment is used with a high rate in the treatment of patients diagnosed with End Stage Renal Failure.

Hemodialysis patients experience loneliness and hopelessness during their difficult and compulsory treatmet. Fear of being alone is an important problem affecting the patient's compliance with treatment. In addition, the other problem these patients experience is hopelessness. Hopelessness is an important factor that affects the patient's expectations for the future and the process of solving problems.

Therapeutic touch is a complementary and alternative treatment method. It is stated that this treatment method, which is successfully used by nurses, is good for loneliness and hopelessness. This method, which will be used on hemodialysis patients, is aimed to get away from the problems of loneliness and hopelessness.

In this study, two scales will be used to measure the loneliness and hopelessness levels of hemodialysis patients. Patients will fill in UCLA Loneliness Scale and BECK Hopelessness Scale.

Nurses should not ignore the problems of loneliness and hopelessness in hemodialysis patients. Therapeutic touch treatment method wil lprovide nurses the holistic caregiver role for the feelings of loneliness and hopelessness experienced by the patients. When the literature is scanned, this study is unique because it has not been done before on hemodialysis patients.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Having hemodialysis treatment for at least 3 months,
Cognitive patients,
Having a score of UCLA> 20 and BECK≥4 scoring,
Involved in the work with us.

Exclusion criteria

Patients using traditional treatment for the disease were not included in the study.

Treatment and study plan

THERAPEUTİC TOUCH FOR HEMODİALYSİS PATİENTS

Behavioral

Therapeutic touch was applied to hemodialysis patients for 3 days every other day.

Primary outcomes

The effect of therapeutic touch on loneliness in hemodialysis patients

Time frame: Scales are filled after 3 days of application.

Developed by Russell et al. in 1980, the UCLA Loneliness Scale consists of 20 items, 10 of which are straight and 10 of which are reversed. Each item is scored between 1-4. While calculating the loneliness score, the calculation is made by taking the reverse of the scores given to the items used adversely. The highest score that can be obtained from the scale is 80, and the lowest score is 20. Higher scores indicate that individuals experience more loneliness.
The effect of therapeutic touch on hopelessness in hemodialysis patients

Time frame: Scales are filled after 3 days of application.

The scale developed by Beck et al. in 1974 to measure hopelessness consists of 20 items and is scored between 0 and 1. The items in the scale are Emotions and Expectations about the Future (1, 3, 7, 11 and 18), Loss of Motivation (2, 4, 9, 12, 14, 16, 17 and 20), and Hope (5, 6, 8, 10, 13). , 15 and 19) have three sub-dimensions. The lowest score that can be obtained from the scale is 0, the highest score is 20, and a high score indicates a high level of hopelessness.

Sponsors and collaborators

Lead sponsor

Zehra Bayram

Other

Registry information

Official study title

The Effect Of Therapeutic Touch Applied to Hemodialysis Patient On The Level Of Loneliness And Hopelessness

Acronym: nursing

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Aug 27, 2021
Registry last updated: Aug 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed